Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Baker

Showing results (331-340 of 1,278) with videos related to

Pageof 128
Sort By:
AIDS (London, England)|January 3, 2020
Switch from tenofovir disoproxil fumarate to raltegravir is not associated with weight gain over 96 weeksMirella Carr, Robyn Richardson, Winnie Tong, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2013
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysisEleanor James, Ruth Dobson, Jens Kuhle, et al.
Journal of the American Pharmacists Association : Japha|August 31, 2019
Evaluation of a pharmacist-led naloxone coprescribing program in primary careDesmond Cariveau, Allison E Fay, David Baker, et al.
Journal of Neurosurgery. Case Lessons|March 3, 2025
Robot-assisted MRI-guided laser interstitial thermal therapy for a giant sessile hypothalamic hamartoma in an 8-year-old boy: illustrative caseMolly Butler, Christopher Carr, David Baker, et al.
Structure (London, England : 1993)|April 8, 2003
Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligandsBenjamin J McFarland, Tanja Kortemme, Shuyuarn F Yu, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis modelDavid Baker, Erik Nutma, Helen O'Shea, et al.
Multiple Sclerosis and Related Disorders|December 13, 2021
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosisDavid Baker, Amy MacDougall, Angray S Kang, et al.
Pharmaceuticals (Basel, Switzerland)|July 7, 2019
The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca<sup>2+</sup>-Activated K<sup>+</sup> Channels to Modulate Hippocampal CA1 Pyramidal Neuron FiringSetareh Tabatabaee, David Baker, David L Selwood, et al.
Journal of Lipid Research|April 6, 2017
Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff diseaseEmmanuelle Lecommandeur, David Baker, Timothy M Cox, et al.
Archives of Disease in Childhood|April 17, 2014
Complication of percutaneous endoscopic gastrostomyStephen D Adams, David Baker, Arjun Takhar, et al.
Pageof 128

Showing results (331-340 of 1,278) with videos related to

Sort By:
Pageof 128
AIDS (London, England)|January 3, 2020
Switch from tenofovir disoproxil fumarate to raltegravir is not associated with weight gain over 96 weeksMirella Carr, Robyn Richardson, Winnie Tong, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 24, 2013
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysisEleanor James, Ruth Dobson, Jens Kuhle, et al.
Journal of the American Pharmacists Association : Japha|August 31, 2019
Evaluation of a pharmacist-led naloxone coprescribing program in primary careDesmond Cariveau, Allison E Fay, David Baker, et al.
Journal of Neurosurgery. Case Lessons|March 3, 2025
Robot-assisted MRI-guided laser interstitial thermal therapy for a giant sessile hypothalamic hamartoma in an 8-year-old boy: illustrative caseMolly Butler, Christopher Carr, David Baker, et al.
Structure (London, England : 1993)|April 8, 2003
Symmetry recognizing asymmetry: analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligandsBenjamin J McFarland, Tanja Kortemme, Shuyuarn F Yu, et al.
Annals of Clinical and Translational Neurology|August 13, 2019
Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis modelDavid Baker, Erik Nutma, Helen O'Shea, et al.
Multiple Sclerosis and Related Disorders|December 13, 2021
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosisDavid Baker, Amy MacDougall, Angray S Kang, et al.
Pharmaceuticals (Basel, Switzerland)|July 7, 2019
The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca<sup>2+</sup>-Activated K<sup>+</sup> Channels to Modulate Hippocampal CA1 Pyramidal Neuron FiringSetareh Tabatabaee, David Baker, David L Selwood, et al.
Journal of Lipid Research|April 6, 2017
Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff diseaseEmmanuelle Lecommandeur, David Baker, Timothy M Cox, et al.
Archives of Disease in Childhood|April 17, 2014
Complication of percutaneous endoscopic gastrostomyStephen D Adams, David Baker, Arjun Takhar, et al.
Pageof 128